David Roth, Chief Medical Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 4,882 shares at $4.98 ($25K) on 2024-04-02, disclosed to the SEC on 2024-04-02.
Scheduled sale ($25k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.12 | 4,732 | $24K | 97.0% |
| 2 | $4.98 | 150 | $747 | 3.0% |
| Total | $5.12 avg | 4,882 | $25K | 100% |
| Filing → |
| SYRS | SELL | 2023-12-14 | $31K | — | Filing → |
| SYRS | SELL | 2023-12-08 | $25K | — | Filing → |
| SYRS | SELL | 2023-08-02 | $29K | — | Filing → |